In the future for the next 5-10 years, the FMN Laboratory team is aimed at conducting research and development in the field in-vitro and in-patient autonomous diagnostic and treatment complexes, including highly sensitive biosensor systems and lab-on-chip platforms.

Below are the key directions of our studies:

  • Development of a lab-on-chip for the separation of bacteria and viruses
  • Development of a bioanalytical lab-on-chip for molecular diagnostics
  • Development of microfluidic chips to ensure the operation of quantum nanoplasmonics devices
  • Development of technology for the manufacture of giant Raman scattering (SERS) substrates for ultra-high sensitivity biosensors